Clinical Trials Browser

Phase 1 × Unknown × HR Positive/HER-2 Negative Breast Cancer × Clear all

NCT06172322 2024-04-23

A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

Phase 1 Unknown

HR Positive/HER-2 Negative Breast Cancer